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Available online xxxxBackground: The thrombin binding aptamer (TBA) is endowed with antiproliferative properties but its potential
development is counteracted by the concomitant anticoagulant activity.
Methods: Five oligonucleotides (ODNs) based on TBA sequence (GGTTGGTGTGGTTGG) and containing L-residues
or both L-residues and inversion of polarity sites have been investigated by NMR and CD techniques for their
ability to form G-quadruplex structures. Furthermore, their anticoagulant (PT assay) and antiproliferative
properties (MTT assay), and their resistance in fetal bovine serum have been tested.
Results: CD and NMR data suggest that the investigated ODNs are able to form right- and left-handed
G-quadruplex structures. All ODNs do not retain the anticoagulant activity characteristic of TBA but are endowed
with a signiﬁcant antiproliferative activity against two cancerous cell lines. Their resistance in biological
environment after six days is variable, depending on the ODN.
Conclusions: A comparison between results and literature data suggests that the antiproliferative activity of the
TBA analogues investigated could depends on two factors: a) biological pathways and targets different from
those already identiﬁed or proposed for other antiproliferative G-quadruplex aptamers, and b) the contribution
of the guanine-based degradation products.
General signiﬁcance: Modiﬁed TBA analogues containing L-residues and inversion of polarity sites lose the
anticoagulant activity but gain antiproliferative properties against two cancer cell lines. This article is part of a
Special Issue entitled “G-quadruplex” Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio.
© 2016 Published by Elsevier B.V.Keywords:
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RNA and DNA aptamers can be deﬁned as short synthetic ribo- and
deoxyribonucleic acids able to bind, with high afﬁnity and speciﬁcity,
a broad range of molecular targets as small molecules, proteins and
other nucleic acids [1,2]. In general, these remarkable ligands result
from several cycles of an in vitro selection strategy called SELEX
(Systematic Evolution of Ligands by EXponential enrichment) and,
owing to their outstanding properties, are quickly becoming well-
developed tools for numerous applications in research, diagnosis and
therapy [2]. Under certain conditions and in aqueous solution, aptamers
are able to fold in stable three-dimensional structures conferring on
them the ability to bind their cognate ligands. Several DNA/RNA
secondary motifs, as e.g. hairpins, pseudoknots, loops, can belong andplex”Guest Editor: Dr. Concetta
io), galeone@unina.it
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016.09.019contribute to the structural stability of these ligands, this property
being a key feature for the aptamer development and application. A sig-
niﬁcant number of aptamer sequences, discovered by chance or picked
by in vitro selection techniques, adopt K+ ion dependent G-quadruplex
structures, which are among the most stable and common nucleic acids
conformations identiﬁed by this approach [3,4].
Apart from G-quadruplex aptamers with a role in analytics, also
G-quadruplex ligands of therapeutic interest have been identiﬁed
[3,4]. In this frame, the antiproliferative and anticancer G-quadruplex
aptamers have assumed a notable importance, particularly taking into
account their degree of development in clinical investigations [5,6].
A noteworthy example is the aptamer (GGGC)4 (T40214) forming a
parallel G-quadruplex targeting the signal transducer and activator of
transcription 3 protein (Stat3) [7]. Recently, two G-quadruplex DNA
aptamers have been selected against epidermal growth factor receptor
(EGFR)-transfected A549 cells and their antiproliferative properties
have been tested [8]. In 2010 Bates et al. suggested that the cancer-
selective antiproliferative activity may be a general feature of certain
G-rich oligodeoxynucleotides (ODNs) and is associated with the
formation of G-quadruplex structures [9]. In a previous investigation,gues endowed with antiproliferative activity, Biochim. Biophys. Acta
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group of 12 G-quadruplex forming ODNs [8]. Among these, KS-B
(G2T2G2TGTG2T2G2, corresponding to TBA: thrombin binding aptamer)
and GRO29A (T3(G2T)4TG(TG2)4) showed the best two antiproliferative
activities against HeLa cervical carcinoma cells. Afterwards, GRO29A
was proven to be active also without the ﬁrst three thymidines
(AGRO100 or AS1411: (G2T)4TG(TG2)4) [11,12] and, then, the following
detailed investigations were carried out on this sequence [5,13].
Aptamer AS1411 has showed promising antineoplastic effects and sev-
eral studies have indicated that the target of aptamer AS1411 is the sur-
face nucleolin [11,12,14], a multifunctional protein present in the
nucleolus and nucleus of most cells, as well as in the cytoplasm and
on the surface for some cells, including cancer cells and angiogenic en-
dothelial cells. These data suggest that the biological properties of
AS1411 may be attributed to interference with the multitude of
nucleolin-mediated cell processes. In contrast with the large quantity
of biological and pre-clinical studies, only a few investigations have
been devoted to the structural features of the G-quadruplex conforma-
tion adopted by AS1411, probably due to the high degree of polymor-
phism showed by this aptamer [15]. Interestingly, NMR and X-ray
investigations on a sequence derived from that of AS1411, namely
T(G2T)4TG(TG2)3TGT2, showed that it is able to form an unusual left-
handed G-quadruplex structure [16].
Contrarily to the polymorphism of AS1411, TBA folds in a well
deﬁned antiparallel G-quadruplex structure characterized by two
stacked G-tetrads connected through three loops [17,18]. Unfortunately,
the development of TBA as an antiproliferative agent has been severely
counteracted by its concomitant anticoagulant activity and low thermal
stability in physiological condition.
In view of the previous discussion, in developing TBA analogues
potentially endowed with antiproliferative properties, these main
points should be taken into account: 1) the propensity of the sequence
to form a major G-quadruplex structure should be preserved; 2) the
modiﬁed aptamer should retain no or a negligible anticoagulant activity;
3) the resistance of the aptamer to nucleases should be enhanced.
A recent paper has reported that the site speciﬁc replacement of sin-
gle nucleosides into a loopwith a dibenzyl linker is able to switch the ac-
tivity of TBA from anticoagulant to antiproliferative against He-La
cervical carcinoma cells [19]. In previous investigations, we have de-
scribed the preparation of TBA analogues containing L-residues
(whose structures are mirror images of the natural D-residues) or both
L-residues and inversion of polarity sites, in an attempt to obtain modi-
ﬁed aptamers with better properties [20,21]. Here we report data on
some of them (Table 1), concerning both the anticoagulant and the an-
tiproliferative properties on two different cancerous cell lines.2. Materials and methods
2.1. Oligonucleotides synthesis and puriﬁcation
Modiﬁed ODNs reported in Table 1 were prepared and puriﬁed as
previously reported [20,21]. Brieﬂy, ODNs were synthesized on aTable 1
Sequences investigated and their melting temperatures (Tm).
Name
TBA
TBA all–L
D13
IL4
ID6
ULDD
Sequencea
aD and L residues are indicated in upper and lower case, respectively. Inversion of
polarity sites 3’–3’ and 5’–5’ are indicated by a x and a dot, respectively. Loop residues
in the original TBA structure are highlighted in red.
bSee Refs. 20,21.
cAccording to the CD spectra.
Tm (°C)b G–quadruplexc
50
50
52
50
41
42
right–handed
left–handed
left–handed
left–handed
left–handed
right–handed
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phosphoramidite chemistry at 15 μmol scale. The synthesis of the 3′–5′
tracts were performed by using normal 3′-phosphoramidites, 5′-
dimethoxytrityl-β-L-deoxyguanosine (iBu)-3′-phosphoramidite and
5′-dimethoxytrityl-β-L-deoxythymidine-3′-phosphoramidite, whereas
the 5′–3′ tracts were synthesized by using 5′-phosphoramidites.
All modiﬁed phosphoramidite monomers are commercially available
(ChemGenes). For all ODNs an universal support was used.
The oligomers were detached from the support and deprotected by
treatment with concentrated aqueous ammonia at 80 °C overnight.
The combined ﬁltrates and washings were concentrated under
reduced pressure, redissolved in H2O, analyzed and puriﬁed by high-
performance liquid chromatography on a Nucleogel SAX column
(Macherey-Nagel, 1000-8/46), using buffer A: 20 mM KH2PO4/K2HPO4
aqueous solution (pH 7.0) containing 20% (v/v) CH3CN and buffer B:
1 M KCl, 20 mM KH2PO4/K2HPO4 aqueous solution (pH 7.0) containing
20% (v/v) CH3CN; a linear gradient from 0 to 100% B for 45min and ﬂow
rate 1 ml/min were used. The fractions of the oligomers were collected
and successively desalted by Sep-pak cartridges (C-18). The isolated
oligomers proved to be N98% pure by NMR.
2.2. Nuclear magnetic resonance
NMR samples were prepared at a concentration of about
1.5 mM, in 0.6 ml (H2O/D2O 9:1 v/v) buffer solution having
10 mM KH2PO4/K2HPO4, 70 mM KCl and 0.2 mM EDTA (pH 7.0). All
the samples were heated for 5–10 min at 80 °C and slowly cooled
(10–12 h) to room temperature. The solutions were equilibrated for
several weeks at 4 °C. The annealing process was assumed to be com-
plete when 1H NMR spectra were superimposeable on changing time.
NMR spectra were recorded with a Varian Unity INOVA 700 MHz spec-
trometer. 1D proton spectra of the samples in H2Owere recorded using
pulsed-ﬁeld gradient DPFGSE for H2O suppression [22]. 1H-chemical
shifts were referenced relative to external sodium 2,2-dimethyl-2-
silapentane-5-sulfonate (DSS).
2.3. Prothrombin time (PT) assay
PT assay on human plasma samples was measured by using
Koagulab MJ Coagulation System with a speciﬁc kit HemosIL
RecombinPlasTin 2G (Instrumentation Laboratory, Milan, Italy).
Brieﬂy, this method relies on the high sensitivity of thromboplastin
reagent based on recombinant human tissue factors. The addiction
of recombiplastin to the plasma, in presence of calcium ions, initiates
the activation of extrinsic pathway converting the ﬁbrinogen into ﬁ-
brin, with a formation of solid gel. The procedure was performed ac-
cording to the manufacturer's instructions. In our experimental
conditions, each ODN or vehicle was incubated with 100 μl of plasma
at 37 °C for 15 min after that 200 μl of the kit solution containing
recombiplastin was added with consequent activation of extrinsic
pathway. In details, 2 μl of the corresponding ODN solution (1 mM
in PBS) or vehicle (PBS) was added in the apposite microtube, in
order to achieve the ﬁnal concentration of 20 μM. The PT measure-
ment was produced in triplicate and the average and its standard
error values were calculated and expressed as seconds. The basal
clotting time was determined by measuring the clotting time in
absence of any ODN. Incubation with PBS did not modify the PT
measurement.
2.4. Cell cultures and treatments with the ODNs
Human p53 mutated lung cancer Calu-6 (ATCC® HTB-56™) and
p53 null colorectal cancer cell lines HCT 116p53−/− [23] cell lines
were cultured in Dulbecco's Modiﬁed Eagle's Medium (DMEM),
supplemented with 10% fetal bovine serum (FBS) (Euroclone S.p.A),
2 mM L-glutamine and 50 U/ml penicillin-streptomycin, undergues endowed with antiproliferative activity, Biochim. Biophys. Acta
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performed replacing the culture medium with those containing
different ODNs at ﬁnal concentration of 10 μM and 50 μM per well
from 24 h to 144 h.
2.5. MTT assay
Calu-6 [24] and HCT 116p53−/− cells [25] were seeded onto 96-well
plates at density of 2 × 104 cells/well and treatedwith different ODNs at
ﬁnal concentration of 10 μMand 50 μM from 24 h to 144 h. Then, cell vi-
ability was determined using theMTT assay as previously reported [26].
A pool of three different sets of experiments each repeated in triplicate
were performed. Error bars represent mean ± SEM from n = 3
biological replicates. Statistical comparisons were made as previously
shown [27].
2.6. Nuclease stability assay
Nuclease stability of anti-thrombin aptamers was evaluated in
10% fetal bovine serum (FBS) diluted with Dulbecco's Modiﬁed
Eagle's Medium (DMEM) at 37 °C. Approximately 7 nmol of stock
solution of each ODN (~1 O.D.U.) was evaporated to dryness under
reduced pressure and then incubated with 250 μl 10% FBS at 37 °C.
At 0 and 144 h, 125 μl of samples were collected and stored
at−20 °C for at least 20 min. The samples were evaporated to dry-
ness and then 10 μl of gel loading buffer and 10 μl of autoclaved
water were added. 10 μl of the mixture was used for polyacrylamide
gel electrophoresis (PAGE), which was carried out at room tempera-
ture using 20% polyacrylamide gel in 1× TBE buffer (Tris-borate-
EDTA). The degradation patterns on the gel were visualized by UV
shadowing. The band intensity of the stained gel was quantiﬁed by
densitometry with ImageJ software.
3. Results and discussion
3.1. Structural insight of the investigated sequences
It is well known that TBA is able to fold in a peculiarmonomolecular,
antiparallel G-quadruplex structure with a “chair-like” conformation.
The core of the G-quadruplex is characterized by two stacked
G-tetrads in which syn and anti guanosines alternate both in each
G-tetrads and along the strands. Furthermore, the two G-tetrads
are linked to each other by differently sized edge-wise loops:
a central loop (sequence TGT) and two lateral loops (sequence TT)
(Fig. 1) [17,18].
A convincing amount of studies suggested that the two TT loops
represent the most important regions of the aptamer involved in the
interaction with the thrombin anion exosite I and, therefore, they are
mostly responsible for the anticoagulant activity of TBA [28–30].
On the other hand, the same investigations also suggested a minor
role for the TGT loop being able to interact with the heparin
binding site of a further thrombin molecule. Hence, similarly to other
G-quadruplex aptamers, the structure of TBA is characterized by a
central part composed of stacked G-tetrads, mostly accounting for the
thermal stability, and by some loops protruding outward and, then,
more prone to interact with the target proteins. In the selection of TBA
analogues as potential antiproliferative aptamers, we have mainly taken
into account three properties: 1) the ability to form G-quadruplex
structures; 2) the thermal stability in physiological conditions and
3) the chemical resistance in biological environments. Recently, in an
effort to obtain TBA analogues with improved properties, we have
prepared and investigated sequences containing L-nucleotides or both
L-nucleotides and inversion of polarity sites [20,21]. Among these, ODNs
have been chosen showing different composition and strand orientation
of loop sequences in the original chair-like structure (Table 1).Please cite this article as: V. Esposito, et al., Backbone modiﬁed TBA analo
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the occurrence of G-quadruplex structures in solution but also to obtain
information regarding the folding topology, particularly in the case of
sequences analogues of a parent ODN, for which the formation of a
peculiar G-quadruplex has been assessed by other techniques and
whose CD proﬁle is known [31]. In Fig. 2 the CD proﬁles of the ODNs
investigated are shown in comparison with that of the natural TBA.
Since TBA all-L shows the same sequence as TBA but is composed by
only L-residues, its CD proﬁle is perfectly specular to that of TBA, as
expected. Therefore, TBA all-L folds in a left-handed chair-like
G-quadruplex structure that is the mirror image of the TBA structure.
ODN D13 is mostly composed by L-residues, apart from thymidines
forming the two small lateral loops, namely T3, T4, T12 and T13. Its CD
spectrum shows a proﬁle very similar to that of TBA all-L, thus suggest-
ing the occurrence of a left-handed chair-like G-quadruplex structure
also for this case (Fig. 1). ODN IL4 shows sequence and base composi-
tion analogous to D13 but, in this case, two 3′–3′ (in between G2–T3
and G11–T12) and two 5′–5′ (in between T4–G5 and T13–G14) inver-
sion of polarity sites have been introduced with the aim to invert the
strand direction of the small loops TT, in respect toD13. Two further in-
version of polarity sites (one 3′–3′ and one 5′–5′ in between G6–T7 and
T9–G10, respectively) have been added in the sequence of ODN ID6 in
order to invert also the strand direction of the large loop TGT. Also CD
spectra of ODNs IL4 and ID6 show proﬁles similar to that of TBA all-L,
besides slight differences regarding the band intensities and their
wavelengths. Therefore, also for these cases, we proposed left-handed
chair-like G-quadruplex structures (Fig. 1). These results should not be
considered particularly surprising taking into consideration that, in
the cases for which a left-handed G-quadruplex structure has been
proposed, (namely, TBA all-L, D13, IL4 and ID6) all guanosines
forming the two-G-tetrad core in the original chair-like conformation
are L-residues, thus ruling the handedness of the whole structure.
It should be noted that although IL4 and ID6 form both left-handed
G-quadruplex structures, the melting temperature of IL4 is about 9 °C
higher than ID6. Considering their different structures, this datum
should not be considered unexpected. In fact, in the more stable IL4,
residues in G-tetrads and TGT loop (which are the parts mostly respon-
sible for the thermal stability [32–34]) share the same chirality and are
linked through canonical 3′–5′ phosphodiester bonds. On the contrary,
in ID6, residues in the G-tetrads and TGT loop show opposite chirality
and two inversion of polarity sites, thus negatively affecting the
structural stability.
Differently from the other ODNs, sequence of ULDD is the only one
in which four guanosines forming the G-quadruplex stem in TBA are
D-residues while the other belong to the L-series. Therefore, in this
case, there is not a strong factor ruling the G-quadruplex handedness.
In fact, the CD spectrum of ULDD (Fig. 2) shows a proﬁle quite different
from those of the other TBA analogues and their natural counterpart,
being characterized by a negative and a positive band at 245 and
266 nm, respectively. Taking into account a) the resemblance of the
CD proﬁle of ULDD with that of the tetramolecular G-quadruplex
formed by TG4T (Fig. 2), b) the dependence of the CD proﬁle from the
type of the G-tetrad stacking [35] and, c) the relationship between gly-
cosidic bond of L-guanosines and strand directionality in G-quadruplex
structures previously studied [36], for ULDD we proposed the right-
handed chair-like G-quadruplex conformation showed in Fig. 1.
In an attempt to obtain more structural information and to conﬁrm
the presence of G-quadruplexes for the TBA analogues, we have also
recorded 1H NMR spectra. In Fig. 3, the imino and aromatic proton
regions are shown. As expected, TBA all-L showed a spectrum identical
to its enantiomer TBA. In the case of D13, the simple appearance of its
spectrum and the presence of eight partially overlapped signals in the
G-quadruplex diagnostic region between 10.5 and 12.5 ppm (in which
the guanosine imino protons involved in H-bonds occur) clearly
indicated the formation of a well-deﬁned G-quadruplex structure.
More detailed 2D-NMR investigations conﬁrmed a monomoleculargues endowed with antiproliferative activity, Biochim. Biophys. Acta
Fig. 1. Proposed G-quadruplex structures for the ODNs investigated (Table 1). Anti and syn guanosines are indicated in light blue and purple, respectively. The 3′–3′ and 5′–5′ inversion of
polarity sites are indicated by a x and a dot, respectively. Arrows indicate the 5′–3′ orientation. D- and L-residues are labelled in black and red, respectively.
4 V. Esposito et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxchair-like G-quadruplex structure very similar to that of the original
TBA, except for the helix type [20]. Differently from D13 and TBA
all-L, ODNs IL4, ID6 and ULDD have shown 1H NMR spectra character-
ized by large and partially overlapped signals suggesting the presence of
more than one conformation in equilibrium and, then, preventing us to
carry out further detailed investigations. Nevertheless, also in these
cases, the occurrence of signals in the diagnostic region has conﬁrmed
the presence of G-quadruplex structures that was already suggested
by the CD proﬁles.3.2. Biological activity
In order to evaluate the anticoagulant activity of the TBA analogues
(Table 1), the modiﬁed sequences have been subjected to prothrombin
time (PT) assay. This analysis has shown that none of the TBAFig. 2. CD spectra of the ODNs investigated (Table 1) (20 °C in a buffer solution 10mMKH2PO4/
G-quadruplex has been shown as a reference.
Please cite this article as: V. Esposito, et al., Backbone modiﬁed TBA analo
(2016), http://dx.doi.org/10.1016/j.bbagen.2016.09.019derivatives investigated is endowed with an anticoagulant activity,
although high ODN concentrations have been used (Fig. 4).
The antiproliferative properties of the investigated ODNs (Table 1)
have been tested on two different human cancerous cell lines, namely
Calu-6 and HCT 116p53−/−. Two concentrations of ODNs, 10 μM and
50 μM, at different time points from 24 h to 144 h have been tested
for their antiproliferative activities in Calu-6 and HCT 116p53−/− cells,
lung and colon cancer cell lines, respectively. Representative cell
survival curves are given in Figs. 5 and 6. In Calu-6 cells, all ODNs have
been found to have activity (Fig. 5). Among the tested ODNs, ULDD
has the greatest effect on cell viability at both tested concentrations.
Speciﬁcally, ULDD shows the 50% of its antiproliferative activity on
tumor cells after lower incubation times (about 53 h and 52 h for con-
centrations 10 μM and 50 μM, respectively) than those observed for
TBA (about 61 h and 55 h for concentrations 10 μM and 50 μM, respec-
tively) (Table S1). The other ODNshave similar speciﬁcity, but they haveK2HPO4, 70mMKCl, pH= 7, ODN conc. = 1 × 10−4 M). The spectrum of the TG4T parallel
gues endowed with antiproliferative activity, Biochim. Biophys. Acta
Fig. 3. 1H NMR spectra of the ODNs investigated (Table 1). See Experimental section for details.
5V. Esposito et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxbeen less effective in inhibiting cell viability of cancer cells. However, all
tested ODNs reduced the cell viability of Calu-6 cells from 10% to 1%
after 144 h. We have observed ID6, ULDD and TBA active also in HCT
116p53−/− cell line in a time dependent manner (Fig. 6), while TBA
all-L, D13 and IL4 have showed a different trend. In fact, for theseFig. 4. PT values of the modiﬁed TBAs and their natural counterpart at 20 μM ODN
concentration and incubation time of 15 min. See Experimental section for details.
*** = p b 0.001 vs. vehicle, ° = p b 0.05, °° = p b 0.01, °°° = p b 0.001 vs. TBA (n = 3).
Please cite this article as: V. Esposito, et al., Backbone modiﬁed TBA analo
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tion at 10 μM and for DI3 and IL4 also at 50 μM after 96 and 120 h of in-
cubation, respectively. We hypothesize that the observed lower
antiproliferative effect of these ODNs in HCT 116p53−/− cells could be
a consequence of the activation of speciﬁc intracellular signalling path-
ways in response to treatmentwith thesemolecules able to inhibit their
activity. In fact, several reports demonstrate that some chemical com-
pounds exhibit speciﬁc cytotoxicity against a particular cancer cell
type but not others. Furthermore, drug screening efforts have identiﬁed
several compounds with cell type speciﬁcity [37,38].
Our analysis reveals that all tested ODNs exhibited a potent cytotox-
icity in Calu-6 cells whereas the compounds TBA all-L, D13 and IL4
show different cytotoxicity in Calu-6 and HCT 116p53−/− suggesting
that these two cell lines possess distinct survival signals that could
lead to a different half-life of these ODNs. Future analysis of these com-
pounds will have to be performed on additional human cancer cell lines
to determine if this selectivity could conduct to the discovery of novel
speciﬁc anti-lung cancer agents.
3.3. Nucleases stability assay
In order to test the resistance in biological environments, all TBA
analogues were undergone to a degradation assay in fetal bovine
serum and analyzed by gel electrophoresis (Fig. 7). Since the cell
viability measured through the MTT assays has been tested up togues endowed with antiproliferative activity, Biochim. Biophys. Acta
Fig. 5.Antiproliferative activity of ODNsonCalu 6 cell line. Cellswere treatedwith two concentrations ofODNs, 10 μM(A) and50 μM(B), from24 to 144 h. The lineNT (not treated) reports
the cell viability in absence of ODNs. Cell viabilitywas assayed 24, 48, 72, 96, 120 and 144 h after addition of ODNs using theMTT assay. Results are presented as percentage (mean± SEM)
(n = 3) of the control cells. *p b 0.05, **p b 0.01.
6 V. Esposito et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxx144 h, the resistance of ODNs in fetal bovine serum has been evaluated
after the same time. As expected, ODNsmostly composed by L-residues
have shown a slight (IL4 and D13) or no detectable degradation (TBA
all-L) in these conditions, while their natural counterpart TBA has been
completely degraded. On the other hand, ID6 has shown only a partial
resistance, while ULDD has been almost completely degraded. Taking
into consideration that both the 3′- and 5′-ends of all modiﬁed TBA
derivatives show L-residues, it is improbable that the observed degrada-
tion could be due to the exonucleases. A plausible explanation is that,
with a reaction time rather extended, the degradation could be induced
by endonucleases. This assumption is corroborated by the stability trend
observed in these conditions (TBA all-L N IL4 N D13 N ID6 ≫ ULDD)
that is quite in agreementwith the amount of canonical 3′–5′ phosphodi-
ester bonds present in the ODN sequences (0, 2, 2, 4 and 6 for ODNs TBA
all-L, IL4, D13, ID6 and ULDD, respectively).Please cite this article as: V. Esposito, et al., Backbone modiﬁed TBA analo
(2016), http://dx.doi.org/10.1016/j.bbagen.2016.09.0194. Conclusions
Taking into account their structures and targets, the antiproliferative
G-quadruplex aptamers (then potentially endowed with anticancer
properties), appear as group rather heterogeneous of ligands. This
datum is not particularly surprising considering the dependence of the
cellular proliferation on several biological pathways, which implies a
quite high number of potential targets. For example, a compelling
amount of investigations strongly suggest that the target of the most
studied antiproliferative G-quadruplex aptamer, namely the 26-mer
AS1411, is the nucleolin, a multifunctional protein overexpressed in
cytoplasm and on cell surface of many tumor types [39,40]. However,
this frame is complicated by further data, among which are: 1) the
recent ﬁnding that the cytotoxicity of guanine-based degradation
products contributes to the antiproliferative activity of G-richgues endowed with antiproliferative activity, Biochim. Biophys. Acta
Fig. 6. Antiproliferative activity of ODNs on HCT 116p53−/− cell line. Cells were treatedwith two different concentrations of ODNs, 10 μM (A) and 50 μM (B), from 24 to 144 h. The line NT
(not treated) reports the cell viability in absence of ODNs. Cell viability was assayed 24, 48, 72, 96, 120 and 144 h after addition of ODNs using the MTT assay. Results are presented as
percentage (mean ± SEM) (n = 3) of the control cells. *p b 0.05, **p b 0.01.
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extreme polymorphism of aptamer AS1411 [15]. On the other hand, the
16-mer aptamer T40214 (GGGC)4 (and its analogues), forming a
well-deﬁned parallel G-quadruplex structure, is able to link the signal
transducer and activator of transcription 3 protein (Stat3) [7,42],
which is involved in a variety of cellular and biological processes includ-
ing proliferation, differentiation, apoptosis, host defense, and transfor-
mation. Differently from these two aptamers, for which unique targets
have been proposed, and according to literature data, the antiprolifera-
tive activity of TBA would depend on three factors: 1) the ability of TBA
to interact with a protein thought to be nucleolin [10], 2) the involve-
ment of thrombin, the main target of TBA, in promoting proliferation
by interacting with the protease activated receptor-1 (PAR1) [43], and
3) similarly to other G-rich ODNs, the contribution of the guanine-
based degradation products [41], particularly taking into account thePlease cite this article as: V. Esposito, et al., Backbone modiﬁed TBA analo
(2016), http://dx.doi.org/10.1016/j.bbagen.2016.09.019low resistance of TBA to nucleases [44]. Although the anticoagulant
activity of TBA clearly represents a disadvantage in exploiting the
antiproliferative property of this aptamer, a recent research has
shown that suitable chemical sequence modiﬁcations can preserve its
antiproliferative over anticoagulant activity [19]. Following a similar
strategy, in this paper, we have investigated the properties of TBA
analogues containing twomodiﬁcations (Table 1), namely the presence
of L-residues [20,36] and the introduction of inversion of polarity
sites [21,45–47]. NMR and CD data suggest that all ODNs fold in
G-quadruplex structures, although characterized by different helix
types (right- or left-handed). Collected data are consistent with the
occurring of “chair-like” G-quadruplex conformations resembling that
of TBA, also in these cases. Importantly, none of the tested ODNs have
shown anticoagulant activity (Fig. 4), thus suggesting that the TBA ana-
logues are unable to interact with thrombin. However, MTT assaysgues endowed with antiproliferative activity, Biochim. Biophys. Acta
Fig. 7. Stability of the ODNs investigated in 10% fetal bovine serum (FBS), as monitored by non-denaturing PAGE. Time points 0 and 144 are in hours. ODN T23 has been used as positive
control. See the Materials and methods section for experimental details.
8 V. Esposito et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxconcerning two types of cancer cells have indicated antiproliferative
activities, in several cases, comparable with that of the natural TBA,
depending on the cell type, sequence, time of treatment and ODN
concentration. For example, the behavior of TBA all-L and TBA on HCT
116p53−/− cell line at 50 μm of ODN concentration is quite similar
(Fig. 6). On the other hand, for time of treatment of 144 h, the antipro-
liferative activity on Calu 6 cell line has resulted comparable to TBA
for most of the tested ODNs (Fig. 5). NMR and CD data have clearly in-
dicated that, among the ODNs investigated, TBA all-L and D13 adopt
well-deﬁned “chair-like” left-handed G-quadruplex structures [20].
However, contrarily to TBA, their antiproliferative activities cannot be
ascribed neither to the interaction with the thrombin (since they do
not show an anticoagulant activity) neither to the guanine-based prod-
ucts derived from their degradation (since they are quite resistant to
nucleases and their potential degradation products would be mostly
L-residues). On the other hand, although it cannot be ruled out deﬁni-
tively, it is quite improbable that the target is nucleolin also for TBA
all-L and D13, since they adopt left-handed G-quadruplex structures,
which are the mirror image of the TBA one. Interestingly, a possible
relationship between the left-handed G-quadruplex structure adopted
by an AS1411 related ODN [16] and that one formed by TBA all-L and
D13 could be hypothesized. These observations suggest that the anti-
proliferative activity of TBA all-L and D13 could depend on biological
pathways and targets different from those taken into account up to
now. Biochemical experiments in this frame are underway in our labo-
ratories. Similar considerations could be applied also for IL4 and ID6,
similarly showing noteworthy antiproliferative activities (particularly
against Calu-6 cell line), although, in these cases, their partial degrad-
ability does not allow to rule out completely the contribution of the
guanine-based degradation products. Taking into consideration the
low biological resistance of ULDD, which among the other ODNs has
shown the most interesting results, the contribution of the guanine-
based degradation products to the antiproliferative activity could be
even higher than the other TBA derivatives. In the case of ULDD,
a right-handed G-quadruplex structure has been suggested, although
details concerning its conformation are lacking. In order to stabilize its
G-quadruplex structure and increase the biological resistance, we
have planned the preparation of derivatives containing site-speciﬁc
replacement of guanosines supposed to adopt anti and syn glycosidic
conformations, with modiﬁed nucleotides known to promote them
(as for example, LNA [48] and 8-methyl-2′-deoxyguanosine [49,50]
residues, respectively), with the aim to investigate the involvement
of different biological pathways and targets in the observed
antiproliferative activity.Please cite this article as: V. Esposito, et al., Backbone modiﬁed TBA analo
(2016), http://dx.doi.org/10.1016/j.bbagen.2016.09.019Transparency document
The Transparency document associated with this article can be
found, in online version.
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